Lwmg LLC Buys 768 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Lwmg LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 50.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,287 shares of the healthcare conglomerate’s stock after buying an additional 768 shares during the quarter. Lwmg LLC’s holdings in UnitedHealth Group were worth $1,337,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Thrive Wealth Management LLC boosted its position in shares of UnitedHealth Group by 4.2% during the 3rd quarter. Thrive Wealth Management LLC now owns 1,924 shares of the healthcare conglomerate’s stock valued at $1,125,000 after acquiring an additional 78 shares during the last quarter. AMI Investment Management Inc. grew its stake in UnitedHealth Group by 2.0% in the 3rd quarter. AMI Investment Management Inc. now owns 5,061 shares of the healthcare conglomerate’s stock worth $2,959,000 after buying an additional 99 shares in the last quarter. Peoples Bank KS purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $983,000. jvl associates llc grew its position in UnitedHealth Group by 5.1% in the third quarter. jvl associates llc now owns 492 shares of the healthcare conglomerate’s stock worth $288,000 after acquiring an additional 24 shares in the last quarter. Finally, Chemung Canal Trust Co. lifted its stake in UnitedHealth Group by 0.4% during the third quarter. Chemung Canal Trust Co. now owns 5,180 shares of the healthcare conglomerate’s stock worth $3,029,000 after purchasing an additional 21 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Argus boosted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Tuesday. Morgan Stanley upped their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. UBS Group boosted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. Finally, Truist Financial lifted their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $614.17.

UnitedHealth Group Stock Down 0.3 %

Shares of UNH traded down $1.55 on Friday, reaching $591.20. The stock had a trading volume of 2,463,201 shares, compared to its average volume of 3,965,528. The company has a 50-day simple moving average of $582.24 and a 200-day simple moving average of $527.36. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The firm has a market capitalization of $544.13 billion, a price-to-earnings ratio of 36.14, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter in the prior year, the company earned $6.14 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Insiders Place Their Bets

In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.